Dandrit Biotech USA Inc (DDRT) 5.2500 $DDRT
DanDrit Biotech USA enters into final collaboration agreement for VIVA with the GISCAD Foundation
M2 - Wed Apr 29, 4:38AM CDT
Biotechnology company DanDrit Biotech USA (OTCBB

DRT) disclosed on Tuesday the execution of a final agreement for VIVA in collaboration with GISCAD Foundation, which is engaged in the management of clinical trials, which are aimed at improving clinical practices in patients care, and not for commercial purpose.
DanDrit Biotech USA, Inc. Announces Final Collaboration Agreement with the GISCAD Foundation
PR Newswire - Tue Apr 28, 8:00AM CDT
DanDrit Biotech USA, Inc. ("DanDrit"

(OTC

DRT), a biotechnology company developing a vaccine for the treatment of colorectal cancer, is pleased to announce that it has signed a final collaboration agreement with GISCAD Foundation, a highly recognized Italian group with a focus on digestive tract cancer studies.
DanDrit Biotech and Riyadh Pharma Sign Partnership Agreement
PR Newswire - Thu Apr 23, 12:26PM CDT
DanDrit Biotech A/S ("DanDrit Denmark"

, the subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"

, (symbol : OTCQB

DRT) a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, announced that DanDrit and the Pharmaceutical Company Riyadh Pharma have signed a partnership agreement in Saudi Arabia.